
Rosuvastatin
Rosuvastatin is a potent statin. In a 6-week label study, 5 to 40 mg lowered LDL cholesterol by 45 to 63 percent, and in two large trials it reduced heart attacks and strokes in people without known heart disease. Large trials found no reduction in heart events or deaths in chronic heart failure or in people on hemodialysis. Grapefruit-type interactions matter less than with simvastatin, but some prescription drugs, aluminum-magnesium antacids and red yeast rice do matter.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with high LDL cholesterol or increased cardiovascular risk, and some children with familial high cholesterol, treated and monitored by a prescriber
Common dosing range
Set by your prescriber. The Crestor label gives 5 to 40 mg once daily for adults; Asian patients start at 5 mg, and severe kidney impairment starts at 5 mg with a 10 mg maximum
When to expect effects
LDL falls within weeks; the label says the maximum LDL reduction is usually reached by 4 weeks. Fewer heart events were seen within about 2 years in JUPITER
Watch out for
Muscle injury (myopathy, rarely rhabdomyolysis) is more likely at 40 mg, after age 65, with kidney impairment or untreated low thyroid, in Asian patients, and with drugs such as cyclosporine, gemfibrozil and some antivirals. Aluminum and magnesium hydroxide antacids taken at the same time halved rosuvastatin absorption. Statins lower blood CoQ10, but evidence that CoQ10 pills relieve muscle aches is mixed
What is it
Rosuvastatin is a prescription cholesterol-lowering medicine in the statin class, sold as Crestor and as generic rosuvastatin calcium tablets. It is used to lower LDL ("bad") cholesterol, to slow the buildup of plaque in arteries, and to reduce the risk of heart attack, stroke and related events in adults at increased cardiovascular risk. It is also approved for some children with inherited (familial) high cholesterol. Unlike simvastatin, lovastatin and atorvastatin, rosuvastatin is not broken down to a meaningful extent by the CYP3A4 enzyme that grapefruit blocks. Its blood level depends instead on liver transport proteins (OATP1B1 and BCRP) and, to a small degree, the CYP2C9 enzyme, and several prescription drugs can block these.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
heart attack and stroke prevention in adults without heart disease Strong Evidence | About 24 to 44 percent fewer major cardiovascular events; about 1 percentage point absolute reduction over 5.6 years in HOPE-3 | Older adults without known heart disease who have raised CRP or intermediate cardiovascular risk | Differences emerged within about 2 years |
LDL cholesterol Strong Evidence | About 43 to 50 percent lower LDL in trials of 10 to 20 mg | Adults with high LDL cholesterol | Weeks |
heart events and survival in chronic heart failure Strong Evidence | No significant difference in major events or deaths | Not applicable | Assessed over about 3 to 4 years |
heart events in people on hemodialysis Good Evidence | No significant difference in major cardiovascular events or deaths | Not applicable | Assessed over 3.8 years |
heart attack and stroke prevention in adults without heart disease
- Effect
- About 24 to 44 percent fewer major cardiovascular events; about 1 percentage point absolute reduction over 5.6 years in HOPE-3
- Best fit
- Older adults without known heart disease who have raised CRP or intermediate cardiovascular risk
- Time
- Differences emerged within about 2 years
LDL cholesterol
- Effect
- About 43 to 50 percent lower LDL in trials of 10 to 20 mg
- Best fit
- Adults with high LDL cholesterol
- Time
- Weeks
heart events and survival in chronic heart failure
- Effect
- No significant difference in major events or deaths
- Best fit
- Not applicable
- Time
- Assessed over about 3 to 4 years
heart events in people on hemodialysis
- Effect
- No significant difference in major cardiovascular events or deaths
- Best fit
- Not applicable
- Time
- Assessed over 3.8 years
Evidence for 4 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
heart attack and stroke prevention in adults without heart disease
Disease adjunctJUPITER randomized 17,802 healthy men 50 and older and women 60 and older with LDL below 130 mg/dL and a high-sensitivity CRP of 2 mg/L or more to rosuvastatin 20 mg or placebo. It was stopped early after a median 1.9 years: the combined rate of heart attack, stroke, revascularization, hospitalization for unstable angina or cardiovascular death was 0.77 versus 1.36 per 100 person-years (hazard ratio 0.56). Heart attacks (hazard ratio 0.46) and strokes (0.52) were both lower, and death from any cause was 20 percent lower. HOPE-3 then gave rosuvastatin 10 mg or placebo to 12,705 intermediate-risk adults in 21 countries for a median 5.6 years: cardiovascular death, heart attack or stroke occurred in 3.7 versus 4.8 percent (hazard ratio 0.76). Trials stopped early can overstate benefit, and the absolute difference in HOPE-3 was about 1 percentage point over 5.6 years. Physician-reported diabetes was more common on rosuvastatin in JUPITER, and muscle symptoms (5.8 versus 4.7 percent) and cataract surgery (3.8 versus 3.1 percent) in HOPE-3.
Bottom line: Two large trials show rosuvastatin lowers heart attacks and strokes in people at increased risk who do not yet have heart disease.
LDL cholesterol
Biomarker supportIn JUPITER, rosuvastatin 20 mg lowered LDL cholesterol by 50 percent (and high-sensitivity CRP by 37 percent). In HOPE-3, average LDL over 5.6 years was 26.5 percent lower with 10 mg than with placebo.. In AURORA, 10 mg lowered LDL by 43 percent at 3 months in people on hemodialysis, from a mean of 100 mg/dL. LDL is a blood marker: lowering it does not guarantee fewer heart events, as AURORA showed.
Bottom line: A large, reliable LDL reduction.
heart events and survival in chronic heart failure
No benefit foundCORONA gave rosuvastatin 10 mg or placebo to 5,011 people aged 60 or older with ischemic systolic heart failure (NYHA class II to IV) for a median 32.8 months. LDL fell 45 percent, but cardiovascular death, heart attack or stroke was not significantly reduced (hazard ratio 0.92, 95% CI 0.83 to 1.02), nor was death from any cause (0.95); there were fewer hospitalizations for cardiovascular causes (2,193 versus 2,564). GISSI-HF gave 10 mg or placebo to 4,574 Italian adults with chronic heart failure of any cause for a median 3.9 years: 29 versus 28 percent died (hazard ratio 1.00). Both trials found the drug safe in this group. These results apply to starting rosuvastatin for heart failure, not to people who have other reasons to take a statin.
Bottom line: Rosuvastatin did not lower deaths or heart events in chronic heart failure.
heart events in people on hemodialysis
No benefit foundAURORA randomized 2,776 people aged 50 to 80 on maintenance hemodialysis to rosuvastatin 10 mg or placebo for a median 3.8 years. LDL fell 43 percent, but cardiovascular death, heart attack or stroke occurred at 9.2 versus 9.5 events per 100 patient-years (hazard ratio 0.96, 95% CI 0.84 to 1.11), and death from any cause did not differ (hazard ratio 0.96). This is one trial, and it tested starting a statin in people already on dialysis.
Bottom line: Starting rosuvastatin on hemodialysis lowered LDL but not heart events.
How it works
How to take it
What to track
Bottom line: A prescriber sets the dose, with lower starting doses for Asian patients and severe kidney impairment. The main everyday points are antacid timing, interacting prescription drugs and not stacking red yeast rice on top.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Myopathy and rhabdomyolysis (muscle breakdown that can damage the kidneys). The label lists age 65 or older, uncontrolled hypothyroidism, kidney impairment, certain other drugs (including other lipid-lowering therapies) and higher doses as risk factors; risk is greater at 40 mg, and Asian patients may be at higher risk.
Immune-mediated necrotizing myopathy, a rare autoimmune muscle disease with weakness that persists after the statin is stopped
Liver enzyme rises (above 3 times normal in 1.1 percent versus 0.5 percent on placebo in pooled trials) and rare liver failure; people who drink substantial amounts of alcohol or have liver disease may be at higher risk
Protein and microscopic blood in the urine on dipstick tests, more frequent at 40 mg and usually transient; the label suggests considering a lower dose if it persists without explanation
Increases in HbA1c and fasting blood sugar; in JUPITER, diabetes was reported in 2.8 percent on rosuvastatin versus 2.3 percent on placebo
Who should avoid it
- People with acute liver failure or decompensated cirrhosis: contraindicated
- People with a past allergic reaction (rash, itching, hives or angioedema) to rosuvastatin or the tablet ingredients: contraindicated
- People taking sofosbuvir/velpatasvir/voxilaprevir or ledipasvir/sofosbuvir for hepatitis C, gemfibrozil, or tafamidis: the label says to avoid the combination (for gemfibrozil and tafamidis, with lower dose limits if the combination cannot be avoided)
- Pregnant people, unless their doctor has weighed the ongoing need (the label says to stop rosuvastatin when pregnancy is recognized or to weigh the individual need)
- People who are breastfeeding: the label says breastfeeding is not recommended during treatment
Pregnancy & breastfeeding
Pregnancy: the label says rosuvastatin may cause fetal harm based on how it works, and tells prescribers to stop it when pregnancy is recognized or to weigh the patient's ongoing needs; cholesterol treatment is generally not needed during pregnancy. Decades of observational data on statins have not shown a higher rate of major birth defects, but data on miscarriage are insufficient. Breastfeeding: limited case reports show rosuvastatin passes into breast milk, and the label says breastfeeding is not recommended during treatment. If you are pregnant, planning a pregnancy or breastfeeding, talk to your doctor.
Interactions
The Crestor label reports myopathy and rhabdomyolysis when niacin at 1 gram a day or more is combined with rosuvastatin, and asks prescribers to weigh the benefit and watch for muscle symptoms; it also says Asian patients may be at higher risk of myopathy on rosuvastatin. The rate has been measured only with another statin: in HPS2-THRIVE, adding extended-release niacin (with laropiprant) to simvastatin raised definite myopathy about 4-fold and did not significantly reduce major vascular events (13.2 versus 13.7 percent). Do not add high-dose niacin without your prescriber; the small amounts in a multivitamin are a different matter.
These drugs block the transporters that carry rosuvastatin into the liver. In label studies, cyclosporine raised rosuvastatin exposure about 7-fold and sofosbuvir/velpatasvir/voxilaprevir about 7.4-fold, raising the risk of muscle breakdown. The label says to avoid sofosbuvir/velpatasvir/voxilaprevir, ledipasvir/sofosbuvir, gemfibrozil and tafamidis, caps rosuvastatin at 5 mg with cyclosporine, and at 10 mg with several other antivirals. Make sure every prescriber knows you take rosuvastatin.
Red yeast rice contains monacolin K, which is the same molecule as the statin lovastatin, so taking it with rosuvastatin stacks two statins. Testing of 12 products found 0.10 to 10.09 mg of monacolin K per capsule, and 4 had raised levels of citrinin, a toxin that harms the kidneys in animals. The Crestor label lists other lipid-lowering therapies among the risk factors for muscle injury. In a 28-day trial in 190 adults, rosuvastatin 5 mg lowered LDL 35 percent more than placebo, while red yeast rice did not lower it significantly. Review it with your doctor or pharmacist before combining.
Rosuvastatin does not depend on CYP3A4, and in 12 healthy men even 900 mL of pomegranate juice a day did not significantly change levels of simvastatin, a CYP3A4 statin. The concern for rosuvastatin rests on one case report: a 48-year-old man with possible underlying muscle disease, stable on rosuvastatin 5 mg every other day plus ezetimibe, developed rhabdomyolysis 3 weeks after starting pomegranate juice twice a week. Concentrated pomegranate extracts have not been tested. Mention regular pomegranate use to your pharmacist and report unexplained muscle pain or dark urine.
The Crestor label says people who drink substantial amounts of alcohol or have a history of liver disease may be at higher risk of liver injury, and that chronic alcohol-related liver disease modestly raises rosuvastatin levels. Light drinking is not addressed. Discuss your drinking with your doctor, and report yellow skin or eyes or dark urine.
Taken at the same time, a combination aluminum and magnesium hydroxide antacid cut rosuvastatin absorption by about half; taken 2 hours apart, the drop was about 20 percent. The label says to take rosuvastatin at least 2 hours before the antacid. Ask your pharmacist about other magnesium or aluminum products you use.
The label says rosuvastatin significantly raised the INR in people taking warfarin. It tells prescribers to check the INR before starting rosuvastatin and often enough after starting, changing or stopping it until the INR is stable.
Statins lower blood CoQ10 because they block the pathway that makes it; in a meta-analysis of placebo-controlled trials, rosuvastatin lowered plasma CoQ10 by about 0.49 micromol/L, similar to other statins. In the CORONA heart failure trial, rosuvastatin lowered CoQ10, but people with low CoQ10 did not do worse on it. Whether CoQ10 pills ease statin muscle aches is unsettled: one meta-analysis of 12 trials found less muscle pain, another of 7 trials found no benefit. This is not a harmful combination; if you have muscle symptoms, talk to your prescriber before adding anything.
In human liver cells grown in a lab, berberine increased the OATP1B1 transporter and the uptake of rosuvastatin into the cells. No human or animal study has shown that this changes rosuvastatin blood levels, cholesterol response or side effects. Tell your doctor or pharmacist before adding berberine, and report new muscle pain or weakness.
Soluble oat fiber may bind statins in the gut. The evidence comes from mice fed atorvastatin with oat bran, where the cholesterol-lowering effect of a low statin dose was halved; it has not been tested with rosuvastatin in people. Ask your pharmacist whether to space a large oat-fiber supplement apart from your dose.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (4)
+ niacin
highNiacin taken at cholesterol-lowering amounts (1 gram a day or more) adds to rosuvastatin's risk of muscle injury, including rhabdomyolysis, a rare but severe breakdown of muscle that can harm the kidneys. The Crestor label reports cases of myopathy and rhabdomyolysis with lipid-modifying doses of niacin and asks prescribers to weigh the benefit against that risk and to monitor for muscle symptoms; it does not give a rate. The rate was measured with simvastatin, another statin: in a trial of 25,673 adults, adding extended-release niacin raised definite myopathy about 4-fold and did not reduce major vascular events. The small amounts of niacin in a multivitamin are not what the label describes.
+ red yeast rice
moderateRed yeast rice contains monacolin K, a compound chemically identical to a statin, so taking it alongside rosuvastatin stacks a second statin-like HMG-CoA reductase inhibitor on top of the prescription statin. Because rosuvastatin is not broken down by the CYP3A4 enzyme, there is no enzyme-based (pharmacokinetic) interaction; the concern is purely additive statin-class exposure. This modestly raises the combined potential for statin-type muscle injury (myopathy, and rarely rhabdomyolysis) and liver injury beyond either agent alone. The added statin burden is usually small because red yeast rice's monacolin content is typically low, highly variable, and not shown on the label, but unregulated high-monacolin products can carry a more meaningful statin-like load.
+ berberine
lowRosuvastatin is carried into liver cells by the OATP1B1 transporter. In a laboratory study using human liver-cell cultures, berberine increased OATP1B1 activity and pushed more rosuvastatin into the cells. This is an early, test-tube signal only: there is no human or animal data showing it changes blood levels, cholesterol response, or side-effect risk in real life.
+ coq10
lowRosuvastatin blocks HMG-CoA reductase, the enzyme that makes both cholesterol and coenzyme Q10, so it modestly lowers circulating CoQ10. A meta-analysis of placebo-controlled trials found the drop was similar for rosuvastatin and for fat-soluble statins. Mitochondrial impairment is only one proposed mechanism for statin-associated muscle symptoms. This is a possible-benefit pairing, not a dangerous one.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I take red yeast rice with rosuvastatin?⌄
Not without your prescriber's agreement. Red yeast rice contains monacolin K, the same compound as the prescription statin lovastatin, in amounts that varied 100-fold between products in one analysis, so taking both means taking two statins. In a 28-day trial, rosuvastatin 5 mg lowered LDL by about a third more than placebo, while red yeast rice did not lower it significantly.
Should I take CoQ10 with rosuvastatin?⌄
Rosuvastatin does lower CoQ10 in the blood, by about the same amount as other statins. Whether CoQ10 supplements help statin muscle aches is unclear, because meta-analyses disagree. The combination is not harmful, but if you have muscle symptoms, ask your doctor to look for causes and discuss the options; do not stop rosuvastatin on your own.
Are bergamot or berberine safe with rosuvastatin?⌄
There is no strong evidence of harm, and the grapefruit-type mechanism of bergamot matters little because rosuvastatin does not depend on CYP3A4. Berberine changed a rosuvastatin transporter in lab-grown liver cells, but no human study shows an effect on blood levels. Both are sold to lower cholesterol, so tell your prescriber or pharmacist if you use them, since they can change your LDL results.
Do antacids affect rosuvastatin?⌄
Yes, antacids containing aluminum and magnesium hydroxide can. Taken at the same time, one cut rosuvastatin absorption by about half. The label says to take rosuvastatin at least 2 hours before the antacid. Your pharmacist can tell you whether other stomach or magnesium products you use need spacing too.
Why do some people start rosuvastatin at a lower dose?⌄
Blood levels of rosuvastatin are about 2 times higher in Asian patients and about 3 times higher in severe kidney impairment, so the label starts both groups at 5 mg. Several medicines, such as cyclosporine and some antivirals, also raise levels and come with dose caps. Higher levels raise the risk of muscle injury, which is why your prescriber matches the dose to you.
What muscle symptoms should I report on rosuvastatin?⌄
Unexplained muscle pain, tenderness or weakness, especially with fever or feeling generally unwell, and dark or cola-colored urine. These can be signs of myopathy or rhabdomyolysis, which are rare but more likely at 40 mg, with interacting drugs, after age 65, and with kidney or untreated thyroid problems. Contact your prescriber promptly.
References by claim
heart attack and stroke prevention in adults without heart disease
LDL cholesterol
Fellström et al., 2009 · PubMed (2009) link
heart events and survival in chronic heart failure
Safety
Crestor (rosuvastatin) tablets prescribing information · DailyMed (FDA label) link
Interaction: Red yeast rice
Interaction: Pomegranate and pomegranate juice
Interaction: Coenzyme Q10 (CoQ10)
Interaction: Niacin at cholesterol-lowering doses (1 gram a day or more)
Interaction: Berberine
Liu et al., 2020 · PMC (2020) link
Interaction: Oat fiber and oat bran
Eussen et al., 2011 · PubMed (2011) link
Track Rosuvastatin with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
